Latest News and Press Releases

NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Akebia Therapeutics, Inc. (“Akebia” or the “Company”) (NASDAQ: AKBA) and...

NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DiDi Global Inc. (“DiDi” or the “Company”) (NYSE: DIDI). Such investors are advised to...

NEWARK, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP, Hagens Sobol Shapiro LLP, and The Rosen Law Firm, P.A. announce that the United States District Court for the District of New Jersey...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM).   Such investors are...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pulse Biosciences, Inc. (“Pulse” or the “Company”) (NASDAQ: PLSE).   Such investors are...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SunPower Corporation (“SunPower” or the “Company”) (NASDAQ: SPWR).   Such investors are...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astra Space, Inc. f/k/a Holicity Inc. (“Astra Space” or the “Company”) (NASDAQ: ASTR).  ...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telos Corporation (“Telos” or the “Company”) (NASDAQ: TLS).   Such investors are advised...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB).   Such investors are advised to...

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TAL Education Group (“TAL” or the “Company”) (NYSE: TAL).   Such investors are advised to...